GI Innovation Inc
358570
Company Profile
Business description
GI Innovation Inc is a bio-venture company that researches and develops protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART platform.
Contact
Songpa-daero 167
Room 1116 of A-dong
Songpa-gu
Seoul05855
KORT: +82 24042003
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
80
Stocks News & Analysis
stocks
Are small caps finally back?
Does renewed investor interest point to a structural shift in the underperforming factor?
stocks
Chart of the Week: Modest earnings growth at odds with overvalued bank shares
The latest update from our Industry Pulse report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,321.10 | 10.80 | -0.12% |
| CAC 40 | 8,206.87 | 51.99 | -0.63% |
| DAX 40 | 24,151.13 | 178.90 | -0.74% |
| Dow JONES (US) | 46,602.33 | 322.41 | -0.69% |
| FTSE 100 | 9,533.90 | 106.91 | 1.13% |
| HKSE | 25,781.77 | 245.78 | -0.94% |
| NASDAQ | 22,725.88 | 227.78 | -0.99% |
| Nikkei 225 | 49,307.79 | 8.27 | -0.02% |
| NZX 50 Index | 13,306.44 | 71.41 | -0.53% |
| S&P 500 | 6,698.82 | 36.53 | -0.54% |
| S&P/ASX 200 | 9,030.00 | 10.30 | -0.11% |
| SSE Composite Index | 3,913.76 | 2.57 | -0.07% |